Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR3 | Q99500 | 13/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 11/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | PLAU | P00749 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16540985 | 0.84 | PLAU (0.36) | S1PR3S1PR1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL2131576 | 0.82 | MAPK1 (0.46) | S1PR3S1PR1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL4452273 | 0.81 | ALDH1A1 (0.56) | L3MBTL1LMNAALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL22729790 | 0.72 | S1PR3 (0.44) | S1PR3S1PR1S1PR2S1PR4 | |
| SCHEMBL895506 | 0.71 | L3MBTL1 (0.42) | S1PR3S1PR1L3MBTL1LMNAMAPK1 | |
| SCHEMBL29355151 | 0.68 | KMT2A (0.46) | S1PR3S1PR1L3MBTL1LMNACYP2C9 | |
| SCHEMBL22530887 | 0.68 | KMT2A (0.46) | S1PR3S1PR1L3MBTL1LMNACYP2C9 | |
| SCHEMBL15018895 | 0.68 | AKR1C4 (0.33) | TSHRSMN1; SMN2 | |
| SCHEMBL11522882 | 0.67 | LMNA (0.45) | S1PR3S1PR1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL940332 | 0.66 | MAPK1 (0.40) | S1PR3S1PR1L3MBTL1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651604-B1 | N-´2-(2-PYRIDINYL)ETHYL BENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | BAYER SAS (FR) | 2014-11-12 | — | — | EP | disclosed |
| US-7723364-B2 | N-[2-(2-pyridinyl) ethyl]benzamide compounds and their use as fungicides | BAYER CROPSCIENCE SA (FR) | 2010-05-25 | — | — | US | disclosed |
| US-20060246102-A1 | N-'2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides | BAYER SAS (FR) | 2006-11-02 | — | — | US | disclosed |
| EP-1651604-A2 | N-¬2-(2-PYRIDINYL)ETHYL|BENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | Bayer CropScience S.A. (FR) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005014545-A2 | N-′2-(2-PYRIDINYL) ETHYLBENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE S.A. (FR) | 2005-02-17 | — | — | WO | disclosed |
| EP-1500651-A1 | N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides | Bayer CropScience S.A. (FR) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246102-A1 | N-'2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides | CYP1A2, CYP4B1, CYP1B1 | S1PR3 2847/4885S1PR1 2662/4885L3MBTL1 4183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.